CARL

Carlsmed, Inc.

$17.30

-6.99%
SectorHealthcareIndustryHealth Information ServicesCountryUnited States

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Source: Yahoo Finance
AI summary

Price & performance

1M+29.0%
3M+35.5%
YTD+59.9%
1Y+52.7%
52-week range—
Beta1.47
Full chart and returns against a benchmark

Q-Score

53/ 100

Quality against peers; 50 is the peer median.

Growth60
Risk61
Performance53
Valuation46
Profitability51
Leverage48
Sentiment65
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$50.5M+85.9%
Net income-$29.6M
Net margin-58.7%+30.6 pts
Historical fundamentals

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

CARLIndustryP/E—67.40P/S6.614.25EV/EBITDA—44.97P/B6.266.14PEG—0.25
Dividend yield0.00%
Every valuation metric

Earnings

Nov 10next report, after the close
EPS estimate$-0.39
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate